The founding members of Chimera Research Group have over 50 years of combined experience in the biotech and pharmaceutical sector. Their experience includes work at Investment Banks, Hedge Funds, Pharmaceutical Companies, top-tier Universities, and the U.S. Food and Drug Administration (FDA). Their published work includes freelance and editorial contributions both print and on-line, clinical and medical research, books and tutorials, as well as contributions to on-line social media. Through these and other activities they were able to collaborate and connect amongst themselves to establish this cadre of like-minded biotech/pharma trading and investing aficionados. The Team includes: Chief Scientific Analyst - Jason Chew Chief Research Analyst - Patrick Crutcher Chief Medical Analyst - Dr. Tro Kalayjian CEO & Trading Analyst - Tony Pelz Research Analyst - Dr. Andrew Goodwin Research Analyst - Dr. Juan Pedro Rodríguez Serrate Technical Analyst - Joe Gantoss Research Analyst - Dr. Steven Murphy
I am a self-taught investor. My initial interest in stocks and the market began as a Sophomore in college. Since then I have been learning and reading everything I could get my hands on to the point where I am now comfortable and profitable in various trading styles. Given my career as a financial professional, I have also been able to learn how private company sales are made and how other traders on Wall Street trade. I currently am a value investor and also invest / trade short-term momentum, special situations, and growth stocks. I have recently started trading currency.